A placebo-controlled, randomized clinical trial of Bioeffective A in the management of acute alcohol withdrawal and alcohol abstinence maintenance
Phase 2
- Conditions
- alcohol withdrawalalcohol dependenceMental Health - Addiction
- Registration Number
- ACTRN12609000649213
- Lead Sponsor
- Professor Jon Currie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Both male and female patients admitted to a community-based, residential inpatient treatment unit requesting alcohol withdrawal and ongoing alcohol abstinence maintenance, who have alcohol intake of 6 or more drinks per day over at least the past 3 months.
Exclusion Criteria
Inability to take oral medication.pregnancy or breast feeding.known allergy to Bioeffective A, already receiving Bioeffective A, previous treatment for alcohol withdrawal or abstinence maintenance within the past 28 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method